Research Interests
Open to PhD applications in the field of:
- Biologics
- Immunotherapy
- Tumour microenvironment
- Non-thermal electroporation
- Targeted delivery/Theranostics
- Smart and novel nanomaterials
- Prostate and pancreatic cancer
Make a PhD enquiry
Public outreach & key achievements
Research students
| PhD Title |
Fucoidan-based Nanoparticles for Drug Delivery System to Enhance Cancer Immunotherapy |
| Name |
Ms Ungsari Rizki Eka Purwanto |
| Years of Study |
2024 - 2028 |
| Country |
Republic of Indonesia |
| |
|
| PhD Title |
Molecularly Imprinted Nanocarriers for Cancer Immunotherapy |
| Name |
Ms Minao Zhang |
| Years of Study |
2022 - 2025 |
| Country |
China |
| |
|
| PhD Title |
Developing mRNA-Nanomedicines to Potentiate Immunotherapy in Pancreatic Cancer |
| Name |
Ms Raghad Qadadeh |
| Years of Study |
2022 - 2025 |
| Country |
Jordan |
Alumni: Where are they now
| PhD Title |
Preparation of multifunctional nanoparticles using microfluidics |
| Name |
Dr Calvin Cheung |
| Years of Study |
2016 - 2020 |
| Country |
Hong Kong |
| Current Position |
Senior Technical Officer, The University of Hong Kong, Hong Kong |
| |
|
| PhD Title |
Developing a thermoresponsive targeted nanomedicine for advanced prostate cancer |
| Name |
Dr Sara Pereira |
| Years of Study |
2014 - 2019 (part-time) |
| Country |
Portugal |
| Current Position |
Senior Scientist, AstraZeneca, Cambridge, UK |
| |
|
| PhD Title |
Development of Novel Cupric- Tirapazamine Liposomes for Hypoxia Selective Therapy |
| Name |
Dr Vera Silva |
| Years of Study |
2014 - 2017 |
| Country |
Portugal |
| Current Position |
Oncology Scientist at Engitix Therapeutics, UK |
